Amrize Ltd (AMRZ) stock
Close on Oct 30, 2026Market cap $22.63BP/E 18.2Yield –
Earnings
Amrize's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Amrize's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 16, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 28, 2026after the close | $3.77B | +2.6% | $1.02 | $1.05 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026during market hours | $3.49B | +8.5% | $0.86 | $0.88 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 29, 2026during market hours | $2.18B | – | -$0.21 | -$0.16 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 17, 2026during market hours | $2.84B | – | $0.54 | $0.62 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 28, 2025during market hours | $3.68B | – | $0.98 | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025during market hours | $3.22B | – | $0.78 | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Amrize's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RevenuesGAAP | FY2026 | $12.20B – $12.40B | – | New | Oct 28, 2026 |
| RevenuesGAAP | FY2026 | $12.50B – $12.70B | – | New | Aug 6, 2026 |
| Revenues | FY2026 | $12.29B – $12.52B | $12.29B – $12.52B | Reaffirmed | Apr 29, 2026 |
| Revenues | FY2026 | +4% – +6% | – | New | Feb 17, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $2.95B – $3.05B | – | New | Oct 28, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $3.10B – $3.20B | $3.25B – $3.34B | Lowered | Aug 6, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | +8% – +11% | – | New | Feb 17, 2026 |
| Capital Expenditures | FY2026 | $900.00M | – | New | Oct 28, 2026 |
| Capital ExpendituresGAAP | FY2026 | $900.00M | – | New | Aug 6, 2026 |
| Capital Expenditures | FY2026 | $900.00M | $900.00M | Reaffirmed | Apr 29, 2026 |
| Adjusted Effective Tax Ratenon-GAAP | FY2026 | 23% – 25% | – | New | Oct 28, 2026 |
| Adjusted Effective Tax Ratenon-GAAP | FY2026 | 23% – 25% | – | New | Aug 6, 2026 |
| Corporate Costs | FY2026 | $200.00M | – | Lowered | Oct 28, 2026 |
| Corporate Costs | FY2026 | $200.00M | $200.00M | Reaffirmed | Aug 6, 2026 |
| Effective Tax Rate | FY2026 | 21% – 23% | 21% – 23% | Reaffirmed | Apr 29, 2026 |
| Interest Expense, Net | FY2026 | $340.00M | – | New | Oct 28, 2026 |
| Interest Expense, NetGAAP | FY2026 | $340.00M | – | New | Aug 6, 2026 |
| Interest Expense, Net | FY2026 | $340.00M | $340.00M | Raised | Apr 29, 2026 |
Guidance history
Every forecast Amrize put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 28, 2026 | Capital Expenditures | FY2026 | $900.00M | New |
| Oct 28, 2026 | Adjusted EBITDA | FY2026 | $2.95B – $3.05B | New |
| Oct 28, 2026 | Interest Expense, Net | FY2026 | $340.00M | New |
| Oct 28, 2026 | Adjusted Effective Tax Rate | FY2026 | 23% – 25% | New |
| Oct 28, 2026 | Corporate Costs | FY2026 | $200.00M | Lowered |
| Oct 28, 2026 | Revenues | FY2026 | $12.20B – $12.40B | New |
| Aug 6, 2026 | Capital Expenditures | FY2026 | $900.00M | New |
| Aug 6, 2026 | Adjusted EBITDA | FY2026 | $3.10B – $3.20B | Lowered |
| Aug 6, 2026 | Adjusted Effective Tax Rate | FY2026 | 23% – 25% | New |
| Aug 6, 2026 | Corporate Costs | FY2026 | $200.00M | Reaffirmed |
| Aug 6, 2026 | Interest Expense, Net | FY2026 | $340.00M | New |
| Aug 6, 2026 | Revenues | FY2026 | $12.50B – $12.70B | New |
| Apr 29, 2026 | Capital Expenditures | FY2026 | $900.00M | Reaffirmed |
| Apr 29, 2026 | Adjusted EBITDA | FY2026 | $3.25B – $3.34B | Reaffirmed |
| Apr 29, 2026 | Corporate Costs | FY2026 | $200.00M | Lowered |
| Apr 29, 2026 | Effective Tax Rate | FY2026 | 21% – 23% | Reaffirmed |
| Apr 29, 2026 | Interest Expense, Net | FY2026 | $340.00M | Raised |
| Apr 29, 2026 | Revenues | FY2026 | $12.29B – $12.52B | Reaffirmed |
| Feb 17, 2026 | Capital Expenditures | FY2026 | $900.00M | New |
| Feb 17, 2026 | Adjusted EBITDA | FY2026 | +8% – +11% | New |
| Feb 17, 2026 | Adjusted EBITDA | FY2026 | $3.25B – $3.34B | New |
| Feb 17, 2026 | Effective Tax Rate | FY2026 | 21% – 23% | New |
| Feb 17, 2026 | Interest Expense, Net | FY2026 | $340.00M | New |
| Feb 17, 2026 | Corporate Costs | FY2026 | $200.00M | Lowered |
| Feb 17, 2026 | Revenues | FY2026 | +4% – +6% | New |
| Feb 17, 2026 | Revenues | FY2026 | $12.29B – $12.52B | New |
| Oct 28, 2025 | Capital Expenditures | FY2025 | $700.00M | Reaffirmed |
| Oct 28, 2025 | Adjusted EBITDA | FY2025 | $2.90B – $3.10B | Reaffirmed |
| Oct 28, 2025 | Net Leverage Ratio | FY2025 | 1.5 | Reaffirmed |
| Oct 28, 2025 | Effective Tax Rate | FY2025 | 22% – 24% | Reaffirmed |
| Oct 28, 2025 | Depreciation & Amortization | FY2025 | $850.00M | Reaffirmed |
| Oct 28, 2025 | Revenues | FY2025 | $11.70B – $12.00B | Raised |
| Aug 6, 2025 | Capital Expenditures | FY2025 | $700.00M | New |
| Aug 6, 2025 | Adjusted EBITDA | FY2025 | $2.90B – $3.10B | New |
| Aug 6, 2025 | Net Leverage Ratio by Year-End 2025 | FY2025 | 1.5 | New |
| Aug 6, 2025 | Effective Tax Rate | FY2025 | 22% – 24% | New |
| Aug 6, 2025 | Depreciation & Amortization | FY2025 | $850.00M | New |
| Aug 6, 2025 | Revenues | FY2025 | $11.40B – $11.80B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Amrize filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results